Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer
Top Cited Papers
Open Access
- 2 December 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 93 (5), 539-546
- https://doi.org/10.1002/bjs.5209
Abstract
Background: Women with breast cancer are more frequently being treated with preoperative neoadjuvant chemotherapy. The reliability of sentinel lymph node biopsy (SLNB) following chemotherapy has not been determined. This was a meta-analysis of studies that examined the results of SLNB after preoperative chemotherapy.Methods: Included articles had to meet two criteria. First, patients had to have had operable breast cancer and to have undergone SLNB after preoperative chemotherapy and, second, patients had to have undergone subsequent axillary lymph node dissection. Meta-analyses were performed in which Bayesian hierarchical models were created to estimate the identification rate (IR) and sensitivity of SLNB in this setting.Results: Twenty-one studies were identified that included a total of 1273 patients. The IRs reported ranged from 72 to 100 per cent, with a pooled estimate of 90 per cent. The sensitivity of SLNB ranged from 67 to 100 per cent, with a pooled estimate of 88 (95 per cent confidence interval 85 to 90) per cent. Meta-analyses performed using Bayesian modelling resulted in (posterior) estimates for IR and sensitivity of 91 (95 per cent credible interval 88 to 94) and 88 (95 per cent credible interval 84 to 91) per cent respectively.Conclusion: SLNB is a reliable tool for planning treatment after preoperative chemotherapy.Funding Information
- British Journal of Surgery Research Bursary
This publication has 26 references indexed in Scilit:
- Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: Effect of clinical node status at presentationJournal of the American College of Surgeons, 2004
- Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinomaCancer, 2004
- Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: A pilot studyJournal of Surgical Oncology, 2004
- Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapyJournal of Surgical Oncology, 2003
- Sentinel lymph node biopsy after neoadjuvant systemic therapySurgical Clinics of North America, 2003
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerThe New England Journal of Medicine, 2002
- Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancerAnnals of Surgical Oncology, 2002
- Meta-Analysis of Sentinel Lymph Node Biopsy in Breast CancerJournal of Surgical Research, 1999
- Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurgical Oncology, 1993
- Limited assurancesThe American Journal of Cardiology, 1989